HIV and the kidney: A spotlight on racial disparities

Journal of Infectious Diseases

Volumn 197, Issue 11, 2008, Pages 1490-1492

  Wyatt, Christina M ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Box 1243 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIRETROVIRUS AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COMORBIDITY; DISEASE COURSE; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE DIFFERENCE; SURVIVAL;

CONTINENTAL POPULATION GROUPS; HIV INFECTIONS; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 43949110983     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/587995     Document Type: Editorial

References (20)

1. Rao TK, Filippone EJ, Nicastri AD, et al. Associated FSGS in AIDS. N Engl J Med 1984; 310:669-73.
2. Cantor ES, Kimmel PL, Bosch JP. Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy. Arch Intern Med 1991; 151:125-8.
3. Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 2004;18:541-6.
4. Szczech LA, Gupta SK, Habash R, et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 2004:66:1145-52.
5. US Renal Data System. USRDS 2007 Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007.
6. Abbott KC, Hypolite I, Welch PG, Agodoa LY. Human immunodeficiency virus/ acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era. J Nephrol 2001; 14:377-83.
7. Gerntholtz TE, Goetsch SJW, Katz I. HIV-related nephropathy: a South African perspective. Kidney Int 2006; 69:1885-91.
8. Mocroft A, Kirk O, Gatell J, et al. Chronic renal failure among HIV-1-infected patients. AIDS 2007; 21:1119-27.
9. Wyatt CM, Winston JA, Malvestutto C, et al. Chronic kidney disease in HIV infection: an urban epidemic. AIDS 2007; 21:2101-3.
10. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol 2007; 18:2968-74.
11. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM. The impact of HIV on chronic kidney disease outcomes. Kidney Int 2007; 72:1380-7.
12. Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis 2008; 197:1548-57 (in this issue).
13. Lucas GM, Mehta SH, Atta MG, et al. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS 2007; 21:2435- 43.
14. DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of anti-retroviral agents in HIV-1-infected adults and adolescents. December 1, 2007. Available at http://aidsinfo.nih.gov/ contentfiles/AdultandAdolescentGL.pdf. Accessed 8 April 2008.
15. Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the managementof chronic kidney disease in HIV-infected patients: recommendations of the Infectious Diseases Society of America. Clin Infect Dis 2005; 40:1559-85.
16. Han TM, Naicker S, Ramdial PK, Assounga AG. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 2006; 69:2243-50.
17. Olson D, Thomas E, Allheimen M, Balkan S, Szumilin E, Humblet P. Impaired renal function of patients initiating HAART in two developing countries [abstract 771]. In: 13th Conference on Retroviruses and Opportunistic Infections, February 2006. Available at: http://www.retroconference.org/ Abstract Search/Default.aspx?Conf=15. Accessed 4 April 2008.
18. Agbaji O, Gwanzhi N, Idoko J. Factors affecting the GFR of ARV-naïve HIV-1-infected patients at the Jos Teaching Hospital, Nigeria [abstract CDB0485]. XVI International AIDS Conference, August 2006. Available at: http://www.iasociety.org/Default.aspx?pageId=7. Accessed 4 April 2008.
19. Emem CP, Arogundade F, Sanusi A, Adelusola K, Wokoma F, Akinsola A. Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol Dial Transplant 2007; 23:741-6.
20. Wools-Kaloustian K, Gupta SK, Muloma E, et al. Renal disease in an antiretroviral-naïve HIV-infected outpatient population in Western Kenya. Nephrol Dial Transplant 2007; 22:2208-12.